eMedCodes logo

Treatment Set TS347250 - Treatment Set TS347250

Navigation: NDC > Supplier starting with: A > ANTIGEN LABORATORIES, INC.
Field Value
NDC Code: 49288-0874
Proprietary Name: Treatment Set TS347250
Suffix:
Non-Proprietary Name: Treatment Set TS347250
Dosage Form: INJECTION, SOLUTION
Method: INTRADERMAL; SUBCUTANEOUS
Original Marketing Date: 31-10-1986
Category Name: BLA
Application Number: BLA102223
Labeler: ANTIGEN LABORATORIES, INC.
Substance Name: CARYA ALBA POLLEN; CARYA ILLINOINENSIS POLLEN; FESTUCA PRATENSIS POLLEN; FRAXINUS AMERICANA POLLEN; PASCOPYRUM SMITHII POLLEN; PHLEUM PRATENSE POLLEN; QUERCUS ALBA POLLEN
Active Numerator Strength: .0002; .0002; 20000; .0004; .01; 4000; .0004
Active Ingredient Unit: g/mL; g/mL; [BAU]/mL; g/mL; g/mL; [BAU]/mL; g/mL
Pharm Classes: Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]
DEA Schedule: